Dr Keith Sibson is a Haematology Consultant and his area of expertise is non-malignant haematology. He originally trained as a paediatrician with an interest in haematology-oncology and then undertook further specialist training in adult and paediatric haematology, becoming a fellow of the Royal College of Pathologists in 2009. He was appointed as a consultant at Great Ormond Street Hospital in February 2012, where he has subsequently been the lead for non-malignant haematology. He is also one of three consultants running the haemostasis and thrombosis service. He is actively involved in clinical research in each of these areas.
- Non-malignant haematology
- Haemostasis (congenital and acquired bleeding disorders)
- Immune thrombocytopenia (ITP)
- Autoimmune haemolytic anaemia (AIHA)
- Congenital thrombocytopenias
- Congenital haemolytic anaemias
- Acquired bleeding disorders
- Paediatric thrombosis and anticoagulation
- MBChB 1995
- MRCP (UK) 1998
- FRCPath 2009
- CCST Paediatrics 2006 (Certificate of Completion of Specialist Training)
- CCST Haematology 2011
- Congenital thrombocytopenias
- Thrombosis in cancer
Towner, S., Berger, Z., Titman, P., New, H., Theodore, K., Brown, G., Sibson, K. 2017. The psychological profile of children with immune thrombocytopenia. Submitted to Br J Haematol.
Sibson, K., Biss, T., Furness, C., Grainger, J., Hough, R., Macartney, C., Payne, J., Chalmers, E. 2017. BSH Guideline: Management of thombotic and haemostatic issues in paediatric malignancy. Br J Haematol [in print].
Alwan, F., Vendramin, C., Vanhoorelbeke, K., Langley, K., McDonald, V., Austin, S., Clark, A., Lester, W., Gooding, R., Biss, T., Dutt, T., Cooper, N., Chapman, O., Cranfield, T., Douglas, K., Watson, H., van Veen, J., Sibson, K., Thomas, W., Manson, L., Hill, Q., Benjamin, S., Ellis, D., Westwood, J., Thomas, M., Scully, M. 2017. Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura. Blood
Thachil, J., Bagot, C., Bradbury, C., Cooper, N., Lester, W., Grainger, J., Lowe, G., Evans, G., Talks, K., Sibson, K., Garg, M., Murphy, M., Watson, H., Bolton-Maggs, P., Watson, S., Scully, M., Provan, D., Newland, A., Hill, Q. 2017. A United Kingdom Immune Thrombocytopenia Forum review of practice: thrombopoietin receptor agonists. Br J Haematol [Epub ahead of print].
Fosbury, E., Szychot, E., Slater, O., Mathias, M., Sibson, K. 2017. An 11-year experience of acquired von Willebrand syndrome in children diagnosed with Wilms tumour in a tertiary referral centre. Pediatr Blood Cancer [Epub ahead of print].
Biss, T., Payne, J., Hough, R., Grainger, J., Macartney, C., Sibson, K., Chalmers, E. 2016. Strategies to prevent and manage thrombotic complications of acute lymphoblastic leukaemia in children and young people vary between centres in the United Kingdom. J Pediatr Hematol Oncol.
Fosbury, E., Blumberg, R., Liesner, R., Sibson, K. 2016. Lessons from a neonate with unusual bleeding. J Haem Pract.
Smith, F., Brawand, D., Steedman, L., Oakley, M., Wall, C., Rushton, P., Allchurch, M., Sibson, K., Hemmaway, C., Thein, S., Rees, D., Clark, B. 2015. A comprehensive next generation sequencing gene panel focused on unexplained anaemia. ASH abstract 946.
Shahni, R., Wedatilake, Y., Cleary, M., Lindley, K., Sibson, K., Rahman, S. 2013. A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anaemia (MLASA) phenotype associates with YARS2 mutations. American Journal of Medical Genetics.
O’Connor, D., Sibson, K., Caswell, M., Connor, P., Cummins, M,. Mitchell, C., Motwani, J., Taj, M., Vora, A., Wynn, R., Kearns, P. 2011. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia. British Journal of Haematology.
转诊您的孩子至Keith Sibson 医生